Astonea Labs

What Astonea Labs does

Astonea Labs Limited is a publicly listed Indian pharmaceutical and cosmetics manufacturer headquartered in Chandigarh, with manufacturing operations in Panchkula, Haryana. Founded in 2017 and converted to a public company in January 2024, the company operates a GMP- and ISO-compliant multi-format production facility capable of manufacturing tablets, capsules, syrups, ointments, gels, creams, lotions, oils, and serums across therapeutic categories including antibiotics, antidiabetics, cardiovascular, antihistamines, and nutraceuticals, as well as skincare, haircare, and personal care products.

The business operates three revenue streams. First, third-party/contract manufacturing serves 2,000+ B2B clients across domestic and international markets with end-to-end services from formulation development to packaging. Second, own consumer brands Glow Up and Regero are sold directly through Amazon India and Tata 1MG e-commerce platforms, with an upcoming Avicel skincare line. Third, international exports are active in Iraq and Yemen, with USFDA audit completed for OTC products to enable US market entry via a newly incorporated US subsidiary (Astonea LLC, January 2026). The company claims 1,500+ product approvals and recent strategic investments including ₹6.25 crore into Damaira Pharmaceuticals and a land acquisition in February 2026.

In FY26, Astonea Labs reported revenue of ₹14,758.44 lakh (approximately $17.6M USD), up 51.3% year-over-year, though net profit declined 15.6% to ₹451.52 lakh, indicating margin compression. A fire incident in April 2026 caused ₹9.39 crore in damages with insurance recovery pending. The company's leadership is led by founder and Managing Director Ashish Gulati, with Sumit Kumar as CFO and Ankit Kapoor as Company Secretary. Astonea Labs is listed on BSE (bom:544409) and operates within a group structure including subsidiaries Ascot Biolabs, Shinto Organics, Astonea One, Chemist India, and Astonea Limited.

Name

Astonea Labs

Legal name

Astonea Labs Limited

Website

https://astonea.org

Company type

Public

Founded year

2017

Operating status

Operating

Headcount range

251–500 employees

Short description

Astonea Labs Limited is an Indian pharmaceutical and cosmetics contract manufacturer serving 2,000+ B2B clients with multi-format GMP and USFDA-compliant production, while also marketing own consumer brands Glow Up and Regero via e-commerce and exporting to Iraq and Yemen.

Ownership category

akta.pro rank

Product category

Pharmaceutical Contract Manufacturing

NAICS

Pharmaceutical Preparation Manufacturing (325412), Pharmaceutical and Medicine Manufacturing (3254)

SIC

Pharmaceutical Preparations (2834)

akta.pro primary industry

OTC & Consumer Health Distributors (HLAIAJAC)

Keywords

• Pharmaceutical manufacturing
• Contract manufacturing services
• Cosmetic production
• Personal care products
• Third-party manufacturing

Headquarters

HQ city

Chandigarh

HQ country

India

HQ region

Asia

Offices3 records

Markets served

GTM type

B2B and B2C

Offering type

Services

Cost components

Operations, Supply Chain, Personnel, Technology or R&D, Marketing or Sales, Infrastructure

Revenue model

1. Third-Party/Contract Manufacturing: Provides comprehensive contract manufacturing services for pharmaceutical and cosmetic products to clients across domestic and international markets, offering end-to-end solutions from formulation to packaging with strict quality assurance.
2. Own Brand Sales: Marketing and distribution of proprietary consumer brands including Glow Up, Regero, and the upcoming Avicel skincare line through e-commerce and retail channels.
3. International Exports: Direct exports of pharmaceutical and cosmetic products to countries including Iraq and Yemen, with ongoing expansion initiatives to additional global territories.
4. Raw Materials Trading: Procurement and trading of specialized packaging materials and essential raw materials, supporting company operations and contributing to the broader pharmaceutical and cosmetic supply ecosystem.

Go-to-market motion2 records

Distribution channels3 records

Marketing channels3 records

Core offering

Astonea Labs manufactures pharmaceutical formulations (tablets, capsules, syrups, ointments, creams) and cosmetic/personal care products (gels, lotions, oils, serums) at a GMP- and ISO-certified facility in Panchkula, Haryana. The company primarily operates as a contract manufacturer providing end-to-end formulation development, production, packaging, and quality assurance for third-party pharmaceutical and cosmetic brands, while also marketing its own consumer brands (Glow Up, Regero, and the upcoming Avicel skincare line) via e-commerce channels and exporting products to Iraq and Yemen.

Product overview

Astonea Labs Limited is a diversified pharmaceutical and cosmetics manufacturing company offering two core product lines: (1) Pharmaceutical products including prescription formulations, OTC medicines, specialty pharmaceuticals, nutraceuticals, and topical therapeutics across therapeutic categories such as antibiotics, antidiabetics, cardiovascular drugs, and analgesics; (2) Cosmetic and personal care products including skincare, haircare, body care, and personal hygiene products. The company operates three own consumer brands: Glow Up, Regero, and the upcoming Avicel skincare line. Additionally, Astonea provides third-party/contract manufacturing services for pharmaceutical and cosmetic products to domestic and international clients. Products are exported to Iraq and Yemen, with USFDA audit completed for OTC products enabling entry into the US market.

Differentiator

Problem solved

Functional benefit

Brands

• Glow Up: Cosmetics and personal care brand marketed through e-commerce platforms including Amazon and Tata 1MG
• Regero
• Avicel

Products and services

• Pharmaceutical Products (Contract Manufacturing) Contract manufacturing of pharmaceutical formulations for third-party brands across dosage forms (tablets, capsules, syrups, ointments) and therapeutic categories including antibiotics, anti-diabetics, cardiovascular drugs, antihistamines, analgesics, antifungal agents, gynecological treatments, multivitamins, and dermatological and ophthalmic preparations. Targeted at B2B pharmaceutical companies seeking GMP-compliant production capacity.
• Cosmetic and Personal Care Products (Contract Manufacturing) Contract manufacturing of cosmetic and personal care products including skincare (anti-aging serums, brightening formulations, hydrating moisturizers), haircare (shampoos, conditioners, scalp treatment serums), body care (lotions, scrubs, oils), and personal hygiene essentials for third-party brands. Delivered in formats including gels, ointments, creams, lotions, oils, and serums.
• Third-Party Manufacturing Services Comprehensive end-to-end contract manufacturing services for pharmaceutical and cosmetic products covering formulation development, production, packaging, and quality assurance. Serves B2B clients across domestic Indian and international markets.
• Glow Up (Consumer Brand) Proprietary consumer cosmetic and personal care brand marketed by Astonea Labs and sold directly through e-commerce platforms including Amazon India and Tata 1MG.
• Regero (Consumer Brand) Proprietary consumer cosmetic brand under Astonea Labs' own product portfolio.
• Avicel Skincare Line Upcoming skincare line brand under Astonea Labs, described as soon-to-be-launched in the cosmetic segment.

Quantifiable outcome

• Revenue grew 51.3% to ₹14,758.44 lakh in FY26
• +1 more outcomes

Named customers2 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature4 records

Partnerships

Eight partnerships are on record, tiered core and minor.

• Astonea LLCcoreOthers · 26 January 2026Newly incorporated US subsidiary (wholly-owned subsidiary) for international market expansion. Incorporated on January 26, 2026, as disclosed under SEBI LODR Regulation 30.
• Damaira PharmaceuticalsminorOthers · 1 January 2026Astonea Labs invested ₹6.25 crore in Damaira Pharmaceuticals as part of strategic investment activities.
• Ascot Biolabs Private LimitedcoreOthers · 1 January 2017Group company subsidiary of Astonea Labs Limited, included in group companies structure. Financial statements available from 2023-24.
• Shinto Organics Private LimitedcoreOthers · 1 January 2017Group company subsidiary of Astonea Labs Limited, included in group companies structure. Financial statements available from 2021-22 onwards.
• Astonea One Private LimitedcoreOthers · 1 January 2017Group company subsidiary of Astonea Labs Limited. Financial statements available for 2024-25.
• Astonea FoundationminorOthers · 1 January 2017CSR arm/Foundation of Astonea Labs Limited focused on corporate social responsibility initiatives.
• Astonea LimitedcoreOthers · 1 January 2017Group company with financial statements available for FY 2022-23 through 2024-25.
• Chemist India LimitedcoreOthers · 1 January 2017Group company with financial statements available from FY 2021-22 through 2024-25.

Scale indicators8 records

Recent moves9 records

Expansion highlights5 records

Emerging players

• Honasa Consumer (Mamaearth): Indian DTC personal care brand company selling through e-commerce — comparable on the cosmetics/DTC channel axis to Astonea's Glow Up, Regero, and Avicel branded lines sold via Amazon India and Tata 1MG.
• Evolet Healthcare: Emerging Indian pharmaceutical manufacturer with contract manufacturing capabilities — overlapping with Astonea in the contract manufacturing space but at a smaller, earlier-stage scale.

Broad incumbents

• Gland Pharma: Large Indian injectable-focused pharmaceutical manufacturer with global operations — broader incumbent in Indian pharma manufacturing with established USFDA-cleared facilities, providing a scaled reference point for Astonea's US aspirations.
• Hikal Ltd: Established Indian manufacturer serving pharmaceutical and agrochemical industries with contract manufacturing capabilities — broader incumbent comparable on the contract manufacturing and pharma services axis.
• Emami: Large Indian FMCG company with branded personal care, skincare, and healthcare products — broad incumbent providing a benchmark for branded consumer health/personal care economics relevant to Astonea's own-brand strategy.

Direct peers

• Windlas Biotech: Listed Indian contract pharmaceutical manufacturer serving branded and generic pharma companies with formulations and contract manufacturing services — directly comparable in business model, scale, and listed-status profile to Astonea Labs.
• Medicamen Biotech: Listed Indian pharmaceutical company engaged in formulation manufacturing and contract manufacturing services across therapeutic categories — comparable in listed small-cap pharma contract manufacturing profile.
• Tirupati Medicare: Indian manufacturer of pharmaceutical formulations and personal care/cosmetic products offering contract manufacturing services — directly comparable given Astonea's combined pharma + cosmetics manufacturing focus.
• Synokem Pharmaceuticals: Indian contract manufacturer of pharmaceutical formulations across therapeutic categories including anti-diabetics, cardiovascular, and dermatology — closely matching Astonea's multi-therapy contract manufacturing footprint.
• Akums Drugs & Pharmaceuticals: India's largest contract pharmaceutical manufacturer offering formulation development, manufacturing, and packaging services across multiple dosage forms — directly comparable to Astonea's core B2B pharma contract manufacturing model.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• Facebookfacebook.com/astonealimited

Compliance3 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles12 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Astonea Labs